• Sunitinib - Wikipedia, the free encyclopedia

    en.wikipedia.org/wiki/Sunitinib Sunitinib (marketed as Sutent by Pfizer, and previously known as SU11248) is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was ...
  • RCC | GIST | PNET | SUTENT® (sunitinib malate) Safety Info ...

    www.sutent.com SUTENT® (sunitinib malate) for treatment of advanced renal cell carcinoma, gastrointestinal stromal tumors & advanced pancreatic NET. Risk info for SUTENT®.
  • Sunitinib - Chemotherapy Drugs - Chemocare

    chemocare.com/chemotherapy/drug-info/Sunitinib.aspx Trade Name: Sutent ® Other Name: SU11248. Drug Type: Sunitinib is a targeted therapy and is a receptor protein-tyrosine kinase inhibitor. It inhibits the actions ...
    • Sunitinib (Sutent®) - Cancer information - Macmillan Cancer ...

      www.macmillan.org.uk/Cancerinformation/Cancertreatment/.../Sunitinib.aspx Find out more about sunitinib (also called Sutent®), which may be used to treat a type of kidney cancer called renal cell carcinoma (RCC), gastrointestinal stromal ...
    • Sunitinib (Sutent) | Cancer Research UK

      www.cancerresearchuk.org/about-cancer/cancers-in-general/treatment/.../sunitinib Read about the cancer treatment drug sunitinib, otherwise known as Sutent, including what it is, how it works and possible side effects.
    • FDA Approval for Sunitinib Malate - National Cancer Institute

      www.cancer.gov/about-cancer/treatment/drugs/fda-sunitinib-malate Information from the FDA about the approval of this drug and the clinical trials that led to the approval.
    • Sunitinib medical facts from Drugs.com

      www.drugs.com/mtm/sunitinib.html Sunitinib is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Sunitinib is used to treat certain types of advanced or ...